INSUBCONTINENT EXCLUSIVE:
Shrikant Chouhan of Kotak Securities Limited has sell call on Aurobindo Pharma Ltd
with a target price of Rs 445.0
The current market price of Aurobindo Pharma Ltd
is Rs 467.25 Shrikant Chouhan recommended to keep stoploss at Rs 483
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap
company (having a market cap of Rs 27489.31 Crore) operating in Pharmaceuticals sector
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export
Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to
Sales Value (0.13 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for the year ending
For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 5356.84 Crore, up 2.98 % from last quarter Sales of
Rs 5201.98 Crore and up 28.11 % from last year same quarter Sales of Rs 4181.56 Crore Company has reported net profit after tax of Rs 630.97
Mohan Reddy, Mr.M Sitarama Murthy, Mr.N Govindarajan, Mr.P Sarath Chandra Reddy, Mr.P V Ramprasad Reddy, Mrs.Savita Mahajan
Company has BSR - Associates LLP as its auditoRs As on 30-09-2019, the company has a total of 585,938,609 shares outstanding.